Amplicon details |
||
Amplicon: |
215 bp | |
1 ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg 51 cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa 101 acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc 151 aggatgatct ggacgaagag catcaggggc tcgcgccagc cgaactgttc 201 gccaggctca aggcg |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
NRN_A02741 | nrnl1 | Artificial sequence of pDMI.1 plasmid | 3740 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_BD138563 | nrnl1 | Expression system of nucleotide wit... | 6522 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_AX008868 | nrnl1 | Sequence 8 from Patent WO9964586. ... | 6121 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_AX249945 | nrnl1 | Sequence 3 from Patent WO0166149. ... | 4496 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
DD359480.1 | emblrelpat | Viral vectors and the use of the sa... | 11746 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
DD359481.1 | emblrelpat | Viral vectors and the use of the sa... | 10633 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
DD359482.1 | emblrelpat | Viral vectors and the use of the sa... | 9049 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
DD359483.1 | emblrelpat | Viral vectors and the use of the sa... | 38246 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
DD369632.1 | emblrelpat | Delocalization molecule and use the... | 4151 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
NRN_AX093006 | nrnl1 | Sequence 11 from Patent WO0118192. ... | 8654 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_AX593399 | nrnl1 | Sequence 2 from Patent WO02088752. | 10561 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
JN954974.1 | emblreltgn | Mus musculus targeted non-condition... | 38029 bp | Mus musculus | QL-ELE-00-002 | 215 bp | View |
HL842252.1 | emblrelpat | Sequence 25 from patent US 9353383. | 32339 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_BD138566 | nrnl1 | Expression system of nucleotide wit... | 7546 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
JN954981.1 | emblreltgn | Mus musculus targeted KO-first, con... | 39147 bp | Mus musculus | QL-ELE-00-002 | 215 bp | View |
NRN_AX207725 | nrnl1 | Sequence 23 from Patent WO0157242. ... | 6411 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_AX207740 | nrnl1 | Sequence 38 from Patent WO0157242. ... | 6436 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_AX490645 | nrnl1 | Sequence 13 from Patent EP1223219. ... | 7938 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
JN954987.1 | emblreltgn | Mus musculus targeted KO-first, con... | 37994 bp | Mus musculus | QL-ELE-00-002 | 215 bp | View |
NRN_AX717085 | nrnl1 | Sequence 76 from Patent WO03020939.... | 10036 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.